{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:05:09Z","timestamp":1792872309840,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.mycmed.2022.101304","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T02:43:10Z","timestamp":1655260990000},"page":"101304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of revised EORTC\/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy"],"prefix":"10.1016","volume":"32","author":[{"given":"NA","family":"Acet-\u00d6zt\u00fcrk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"\u00d6mer-Top\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vurat-Acar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6","family":"Ayd\u0131n-G\u00fc\u00e7l\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130E","family":"P\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Demird\u00f6\u011fen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"G\u00f6rek-Dilekta\u015fl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-2501","authenticated-orcid":false,"given":"E","family":"Kazak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"\u00d6zkocaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ursavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Akal\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mycmed.2022.101304_bib0001","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mycmed.2022.101304_bib0002","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mycmed.2022.101304_bib0003","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Invasive fungal infections group of the European organisation for research and treatment of cancer and the global Aspergillus study group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0004","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.mycmed.2022.101304_bib0005","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101304_bib0006","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/myc.12869","article-title":"Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project","volume":"62","author":"Bassetti","year":"2019","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"10.1016\/j.mycmed.2022.101304_bib0007","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.mycmed.2022.101304_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101304_bib0009","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12879-018-3584-9","article-title":"Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies","volume":"18","author":"Dib","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.mycmed.2022.101304_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jinf.2018.02.012","article-title":"The burden of Invasive Aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review","volume":"76","author":"van de Peppel","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.mycmed.2022.101304_bib0011","series-title":"Chief Editor. Fishman's pulmonary diseases and disorders","first-page":"1880","article-title":"Pulmonary infection in immunocompromised hosts","author":"Jay","year":"2015"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101304_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jof7010027","article-title":"a prospective multicenter cohort surveillance study of invasive aspergillosis in Patients with Hematologic Malignancies in Greece: Impact of the revised EORTC\/MSGERC 2020 criteria","volume":"7","author":"Siopi","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.mycmed.2022.101304_bib0013","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/mmy\/myaa007","article-title":"The screening of blood by Aspergillus PCR and galactomannan ELISA precedes BAL detection in patients with proven and probable IA","volume":"58","author":"Springer","year":"2020","journal-title":"Med Mycol"},{"issue":"12","key":"10.1016\/j.mycmed.2022.101304_bib0014","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.mycmed.2022.101304_bib0015","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/cid\/ciaa099","article-title":"The revised definitions for invasive fungal diseases: some advances but questions remain","volume":"71","author":"Mafaciolli","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0016","doi-asserted-by":"crossref","first-page":"e12953","DOI":"10.1111\/tid.12953","article-title":"Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL","volume":"20","author":"Wehrle-Wieland","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101304_bib0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"issue":"9","key":"10.1016\/j.mycmed.2022.101304_bib0018","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/cid\/ciaa104","article-title":"Reply to Mafaciolli and Pasqualotto","volume":"71","author":"Verweij","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0019","article-title":"Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients","volume":"5","author":"de Heer","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mycmed.2022.101304_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/myc.12867","article-title":"False positive bronchoalveolar lavage galactomannan: effect of host and cut-off value","volume":"62","author":"Farmakiotis","year":"2019","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0021","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10096-020-04054-9","article-title":"Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy","volume":"40","author":"Wu","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0022","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1439-0507.2010.01947.x","article-title":"Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC\/MSG 2008 definitions of invasive mould disease","volume":"54","author":"Cornely","year":"2011","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0023","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"Herbrecht","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mycmed.2022.101304_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120370","article-title":"Causes of death in a contemporary cohort of patients with invasive aspergillosis","volume":"10","author":"Garcia-Vidal","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12185-008-0184-2","article-title":"Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies","volume":"88","author":"Auberger","year":"2008","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.mycmed.2022.101304_bib0026","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jmii.2018.01.002","article-title":"Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.mycmed.2022.101304_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216715","article-title":"Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: results from a single-centre study","volume":"14","author":"Fracchiolla","year":"2019","journal-title":"PLoS One"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523322000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:21:44Z","timestamp":1761110504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523322000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1156523322000610"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101304","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of revised EORTC\/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2022.101304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101304"}}